Showing results (381-390 of 668) with videos related to

Sort By:
Pageof 67
Hemasphere|June 7, 2021
Functional Consequences of Mutations in Myeloproliferative NeoplasmsStefan N Constantinescu, William Vainchenker, Gabriel Levy, et al.
Hemasphere|January 6, 2021
Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative NeoplasmsSime Brkic, Sara C Meyer
Hemasphere|July 19, 2021
Correction Notice: A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
Hemasphere|July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell LymphomaErik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.
Hemasphere|July 8, 2021
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell DiseaseJulio Delgado, Caroline Voltz, Milena Stain, et al.
Hemasphere|June 16, 2021
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative NeoplasmsLise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, et al.
Hemasphere|June 17, 2021
Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor CellsKonstantin Byrgazov, Andrej Besse, Marianne Kraus, et al.
Hemasphere|July 15, 2021
The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma CellsMoritz Bewarder, Maximilian Kiefer, Helene Will, et al.
Hemasphere|January 18, 2021
Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and TreatmentJaap A van Doesum, Anne G H Niezink, Gerwin A Huls, et al.
Hemasphere|April 6, 2026
Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemiaMarta Santaliestra, Marta Garrote, María Concepción Fernández-Rodríguez, et al.
Pageof 67